Cargando…

Drug repositioning via host-pathogen protein-protein interactions for the treatment of cervical cancer

INTRODUCTION: Integrating interaction data with biological knowledge can be a critical approach for drug development or drug repurposing. In this context, host-pathogen-protein-protein interaction (HP-PPI) networks are useful instrument to uncover the phenomena underlying therapeutic effects in infe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kori, Medi, Turanli, Beste, Arga, Kazim Yalcin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9905826/ https://www.ncbi.nlm.nih.gov/pubmed/36761959 http://dx.doi.org/10.3389/fonc.2023.1096081

Ejemplares similares

Repositioning of Anti-Inflammatory Drugs for the Treatment of Cervical Cancer Sub-Types
por: Kori, Medi, et al.
Publicado: (2022)

Systems-level biomarkers identification and drug repositioning in colorectal cancer
por: Beklen, Hande, et al.
Publicado: (2021)

Drug Repositioning for P-Glycoprotein Mediated Co-Expression Networks in Colorectal Cancer
por: Beklen, Hande, et al.
Publicado: (2020)

Potential biomarkers and therapeutic targets in cervical cancer: Insights from the meta-analysis of transcriptomics data within network biomedicine perspective
por: Kori, Medi, et al.
Publicado: (2018)

Drug Repositioning for Effective Prostate Cancer Treatment
por: Turanli, Beste, et al.
Publicado: (2018)

Pan-cancer mapping of differential protein-protein interactions
por: Gulfidan, Gizem, et al.
Publicado: (2020)

A Pan-Cancer Atlas of Differentially Interacting Hallmarks of Cancer Proteins
por: Kori, Medi, et al.
Publicado: (2022)

Discovery of therapeutic agents for prostate cancer using genome-scale metabolic modeling and drug repositioning
por: Turanli, Beste, et al.
Publicado: (2019)

Differential Interactome Based Drug Repositioning Unraveled Abacavir, Exemestane, Nortriptyline Hydrochloride, and Tolcapone as Potential Therapeutics for Colorectal Cancers
por: Beklen, Hande, et al.
Publicado: (2021)

Current State of “Omics” Biomarkers in Pancreatic Cancer
por: Turanli, Beste, et al.
Publicado: (2021)

Multi-Omic Data Interpretation to Repurpose Subtype Specific Drug Candidates for Breast Cancer
por: Turanli, Beste, et al.
Publicado: (2019)

The role of protein interaction networks in systems biomedicine
por: Sevimoglu, Tuba, et al.
Publicado: (2014)

Identification of Prognostic Biomarker Signatures and Candidate Drugs in Colorectal Cancer: Insights from Systems Biology Analysis
por: Rahman, Md. Rezanur, et al.
Publicado: (2019)

Repositioning of Antiparasitic Drugs for Tumor Treatment
por: Li, Yan-Qi, et al.
Publicado: (2021)

Pathogen-driven cancers from a structural perspective: Targeting host-pathogen protein-protein interactions
por: Ozdemir, Emine Sila, et al.
Publicado: (2023)

New Drug Repositioning Candidates for T-ALL Identified Via Human/Murine Gene Signature Comparison
por: Bonnet, Raphaël, et al.
Publicado: (2020)

Colchicine as a novel drug for the treatment of osteosarcoma through drug repositioning based on an FDA drug library
por: Oh, Jisun, et al.
Publicado: (2022)

Screening of Drug Repositioning Candidates for Castration Resistant Prostate Cancer
por: Kim, In-Wha, et al.
Publicado: (2019)

A Review of Current In Silico Methods for Repositioning Drugs and Chemical Compounds
por: He, Binsheng, et al.
Publicado: (2021)

Comprehensive Analysis of RNA-Seq Gene Expression Profiling of Brain Transcriptomes Reveals Novel Genes, Regulators, and Pathways in Autism Spectrum Disorder
por: Rahman, Md Rezanur, et al.
Publicado: (2020)

Co-expression Network Analysis Elucidated a Core Module in Association With Prognosis of Non-functioning Non-invasive Human Pituitary Adenoma
por: Aydin, Busra, et al.
Publicado: (2019)

Differential co-expression analysis reveals a novel prognostic gene module in ovarian cancer
por: Gov, Esra, et al.
Publicado: (2017)

Editorial: FDA-Approved Drug Repositioning for P-Glycoprotein Overexpressing Resistant Cancer
por: Yoon, Sungpil, et al.
Publicado: (2021)

New Approaches in Oncology for Repositioning Drugs: The Case of PDE5 Inhibitor Sildenafil
por: Cruz-Burgos, Marian, et al.
Publicado: (2021)

Computational drug repositioning for the identification of new agents to sensitize drug-resistant breast tumors across treatments and receptor subtypes
por: Yu, Katharine, et al.
Publicado: (2023)

Repositioned Drugs for Chagas Disease Unveiled via Structure-Based Drug Repositioning
por: Adasme, Melissa F., et al.
Publicado: (2020)

Human enterovirus 71 protein interaction network prompts antiviral drug repositioning
por: Han, Lu, et al.
Publicado: (2017)

Computational Drug Repositioning for Chagas Disease Using Protein-Ligand Interaction Profiling
por: Juárez-Saldivar, Alfredo, et al.
Publicado: (2020)

Prediction of Drug-Target Interactions and Drug Repositioning via Network-Based Inference
por: Cheng, Feixiong, et al.
Publicado: (2012)

Editorial: Host-pathogen interactions interplay and cancer: understanding mechanisms and beyond
por: Khan, Abdul Arif, et al.
Publicado: (2023)

A Drug Repositioning Approach Identifies a Combination of Compounds as a Potential Regimen for Chronic Lymphocytic Leukemia Treatment
por: Nehdi, Atef, et al.
Publicado: (2021)

An in silico drug repositioning workflow for host-based antivirals
por: Li, Zexu, et al.
Publicado: (2021)

Interplay Between Autophagy and Wnt/β-Catenin Signaling in Cancer: Therapeutic Potential Through Drug Repositioning
por: Pérez-Plasencia, Carlos, et al.
Publicado: (2020)

Repositioning Quinacrine Toward Treatment of Ovarian Cancer by Rational Combination With TRAIL
por: Liang, Rui, et al.
Publicado: (2020)

DPDR-CPI, a server that predicts Drug Positioning and Drug Repositioning via Chemical-Protein Interactome
por: Luo, Heng, et al.
Publicado: (2016)

Subtractive proteomics approach to Unravel the druggable proteins of the emerging pathogen Waddlia chondrophila and drug repositioning on its MurB protein
por: Chowdhury, Umar Faruq, et al.
Publicado: (2021)

Omics-Driven Biomarkers of Psoriasis: Recent Insights, Current Challenges, and Future Prospects
por: Aydin, Busra, et al.
Publicado: (2020)

In silico unravelling pathogen-host signaling cross-talks via pathogen mimicry and human protein-protein interaction networks
por: Mei, Suyu, et al.
Publicado: (2019)

Integrative transcriptomics analysis of lung epithelial cells and identification of repurposable drug candidates for COVID-19
por: Islam, Tania, et al.
Publicado: (2020)

Protein Disulfide Isomerase and Host-Pathogen Interaction
por: Stolf, Beatriz S., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_gm9bok8bgtvm2onm622ikqpchd